Company intelligence / Profile preview

Alpha Win Capital Limited

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

Hong Kong-headquartered private equity firm specializing in equity investments in biopharmaceutical and high technology fields. It manages over US$700 million across 16 Hong Kong Limited Partnership Funds and has invested in over 15 projects. The firm holds Type 1, 4, and 9 licenses from the Hong Kong Securities and Futures Commission and plans to expand its presence in the Greater Bay Area and Mainland China.

Industry: Investors

Beyond the preview

Go deeper on Alpha Win Capital Limited.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha Win Capital Limited.

Explore the full profile